QS Investors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

QS Investors’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-29,610	Closed	-$1.58M	–	2140
2016 Q1	$1.58M	Buy	29,610 +6	+0%	+$443	0.02%	682
2015 Q4	$3.34M	Buy	+29,604	New	+$3.26M	0.03%	528

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

QS Investors's ANAC Position: Q2 2016 in Review

QS Investors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 29,610 shares — an estimated $1.58M sold.

QS Investors first reported a position in ANAC in Q4 2015 and held it in 2 quarters. The position peaked at $3.34M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

QS Investors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
QS Investors sold 29,610 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.58M.
QS Investors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
QS Investors's ANACOR PHARMACEUTICALS INC COM position peaked at $3.34M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on QS Investors's 13F filing for Q2 2016, filed 15 Aug 2016.